Avalon GloboCare Corp. Files 8-K Report

Ticker: ALBT · Form: 8-K · Filed: Jul 18, 2024 · CIK: 1630212

Sentiment: neutral

Topics: 8-K, disclosure, financials

TL;DR

Avalon GloboCare filed an 8-K, mostly routine stuff.

AI Summary

On July 18, 2024, Avalon GloboCare Corp. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or significant events beyond routine reporting were detailed in the provided excerpt.

Why It Matters

This 8-K filing indicates routine corporate reporting by Avalon GloboCare Corp. to the SEC, providing updates on disclosures and financial statements.

Risk Assessment

Risk Level: low — The filing appears to be routine corporate disclosure and does not indicate any immediate significant risks or changes.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Avalon GloboCare Corp.?

The filing is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.

On what date was this 8-K report filed?

The report was filed on July 18, 2024.

In which state is Avalon GloboCare Corp. incorporated?

Avalon GloboCare Corp. is incorporated in Delaware.

What is the principal executive office address for Avalon GloboCare Corp.?

The principal executive office is located at 4400 Route 9 South, Suite 3100, Freehold, NJ 07728.

What is the Commission File Number for Avalon GloboCare Corp.?

The Commission File Number is 001-38728.

Filing Stats: 565 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-07-18 08:37:52

Key Financial Figures

Filing Documents

01. Financial Statement and Exhibits

Item 9.01. Financial Statement and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release of the Company dated July 18, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVALON GLOBOCARE CORP. Dated: July 18, 2024 By: /s/ Luisa Ingargiola Name: Luisa Ingargiola Title: Chief Financial Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing